A clinical-stage biotechnology company developing next-generation cell therapies to modulate the immune system, focusing on umbilical cord lining stem cells for autoimmune diseases and natural killer cell therapeutics for senescence and age-associated disorders. The therapies aim to treat various disabling diseases and enhance patient health outcomes.